Latest PHAS reports update at 2022-08-12: 2022-Q2 ∙ 2022-Q1 ∙ 2021-Q4
  1. Home
  2. Stock quotes
  3. PhaseBio Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals PHAS
$ 0.13 7.4%
mail-toReport an Error

PhaseBio Pharmaceuticals EV/EBITDA Ratio 2011-2024 | PHAS

Annual EV/EBITDA Ratio PhaseBio Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.89 -1.15 -1.88 1.78 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.78 -1.89 -0.786